Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 1139-1143

  Wiley, Jenny L ^a   Golden, Keith M ^a   Ryan, William J ^b   Balster, Robert L ^a   Razdan, Raj K ^b   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ORGANIX INC   (United States)

Author keywords

9 tetrahydrocannabinol; Anandamide; Cannabinoids; Drug discrimination; Fluoroanandamide; Rhesus monkey

Indexed keywords

ANANDAMIDE; CANNABINOID; DRONABINOL; FLUOROANANDAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MACACA MULATTA; MALE; POLYUNSATURATED ALKAMIDES; TETRAHYDROCANNABINOL;

EID: 0031415862     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00327-4     Document Type: Article

References (23)

1. Adams I. B., Ryan W., Singer M., Razdan R. K., Compton D. R., Martin B. R. Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sci. 56:1995;2041-2048.
2. Adams I. B., Ryan W., Singer M., Thomas B. F., Compton D. R., Razdan R. K., Martin B. R. Evaluation of cannabinoid receptor binding and in vivo actitivities for anandamide analogs. J. Pharmacol. Exp. Ther. 273:1995;1172-1181.
3. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci. Biobehav. Rev. 16:1992;55-62.
4. 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology (Berlin). 118:1995;419-424.
5. Borchard R. E., Barnes C. D., Eltherington L. G. Drug dosage in laboratory animals. A handbook 3:1990;Telford Press, Inc, Caldwell, NJ.
6. Carney J. M., Uwaydah I. M., Balster R. L. Evaluation of a suspension system for intravenous self-administration studies of water insoluble compounds in the rhesus monkey. Pharmacol. Biochem. Behav. 7:1977;357-364.
7. Childers S. R., Sexton T., Roy M. B. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47:1994;711-715.
8. Compton D. R., Rice K. C., De Costa B. R., Razdan R. K., Melvin L. S., Johnson M. R., Martin B. R. Cannabinoid structure-activity relationships. Correlation of receptor binding and in vivo activities J. Pharmacol. Exp. Ther. 265:1993;218-226.
9. Crawley J. N., Corwin R. L., Robinson J. K., Felder C. C., Devane W. A., Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46:1993;967-972.
10. Deutsch D. G., Chin S. A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46:1993;791-796.
11. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
12. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J. C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
13. Felder C. C., Briley E. M., Axelrod J., Simpton J. T., Mackie K., Devane W. A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA. 90:1993;7656-7660.
14. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
15. 9-THC and CP 55,940 in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 262:1992;479-486.
16. Huffman J. W., Dai D., Martin B. R., Compton D. R. Design, synthesis and pharmacology of cannabimimetic indoles. BioMed. Chem. Lett. 4:1994;563-566.
17. Jansen E. M., Haycock D. A., Ward S. J., Seybold V. S. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575:1992;93-102.
18. Smith P. B., Compton D. R., Welch S. P., Razdan R. K., Mechoulam R., Martin B. R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270:1994;219-227.
19. Wiley J. L., Balster R. L., Martin B. R. Discriminative stimulus effects of anandamide in rats. Eur. J. Pharmacol. 276:1995;49-54.
20. 9-11-tetrahydrocannabinol in rats and rhesus monkeys. Neuropharmacology. 32:1993;359-365.
21. Wiley J. L., Barrett R. L., Lowe J., Balster R. L., Martin B. R. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology. 34:1995;669-676.
22. 9-tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend. 40:1995;81-86.
23. 9-tetrahydrocannabinol in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1-6.